000177491 001__ 177491
000177491 005__ 20240229133741.0
000177491 0247_ $$2doi$$a10.3389/fimmu.2021.724914
000177491 0247_ $$2pmid$$apmid:34745097
000177491 0247_ $$2pmc$$apmc:PMC8564481
000177491 0247_ $$2altmetric$$aaltmetric:115474883
000177491 037__ $$aDKFZ-2021-02578
000177491 041__ $$aEnglish
000177491 082__ $$a610
000177491 1001_ $$aKaur, Arvinpreet$$b0
000177491 245__ $$aThe Omic Insights on Unfolding Saga of COVID-19.
000177491 260__ $$aLausanne$$bFrontiers Media$$c2021
000177491 3367_ $$2DRIVER$$aarticle
000177491 3367_ $$2DataCite$$aOutput Types/Journal article
000177491 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1637243709_30274$$xReview Article
000177491 3367_ $$2BibTeX$$aARTICLE
000177491 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000177491 3367_ $$00$$2EndNote$$aJournal Article
000177491 520__ $$aThe year 2019 has seen an emergence of the novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease of 2019 (COVID-19). Since the onset of the pandemic, biological and interdisciplinary research is being carried out across the world at a rapid pace to beat the pandemic. There is an increased need to comprehensively understand various aspects of the virus from detection to treatment options including drugs and vaccines for effective global management of the disease. In this review, we summarize the salient findings pertaining to SARS-CoV-2 biology, including symptoms, hosts, epidemiology, SARS-CoV-2 genome, and its emerging variants, viral diagnostics, host-pathogen interactions, alternative antiviral strategies and application of machine learning heuristics and artificial intelligence for effective management of COVID-19 and future pandemics.
000177491 536__ $$0G:(DE-HGF)POF4-312$$a312 - Funktionelle und strukturelle Genomforschung (POF4-312)$$cPOF4-312$$fPOF IV$$x0
000177491 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
000177491 650_7 $$2Other$$aCOVID-19
000177491 650_7 $$2Other$$aORFs
000177491 650_7 $$2Other$$aSARS-CoV-2
000177491 650_7 $$2Other$$aco-morbidities
000177491 650_7 $$2Other$$amachine learning
000177491 7001_ $$aChopra, Mehak$$b1
000177491 7001_ $$aBhushan, Mahak$$b2
000177491 7001_ $$aGupta, Sonal$$b3
000177491 7001_ $$aKumari P, Hima$$b4
000177491 7001_ $$aSivagurunathan, Narmadhaa$$b5
000177491 7001_ $$aShukla, Nidhi$$b6
000177491 7001_ $$aRajagopal, Shalini$$b7
000177491 7001_ $$aBhalothia, Purva$$b8
000177491 7001_ $$aSharma, Purnima$$b9
000177491 7001_ $$aNaravula, Jalaja$$b10
000177491 7001_ $$aSuravajhala, Renuka$$b11
000177491 7001_ $$aGupta, Ayam$$b12
000177491 7001_ $$aAbbasi, Bilal Ahmed$$b13
000177491 7001_ $$aGoswami, Prittam$$b14
000177491 7001_ $$aSingh, Harpreet$$b15
000177491 7001_ $$aNarang, Rahul$$b16
000177491 7001_ $$aPolavarapu, Rathnagiri$$b17
000177491 7001_ $$aMedicherla, Krishna Mohan$$b18
000177491 7001_ $$aValadi, Jayaraman$$b19
000177491 7001_ $$aKumar S, Anil$$b20
000177491 7001_ $$aChaubey, Gyaneshwer$$b21
000177491 7001_ $$aSingh, Keshav K$$b22
000177491 7001_ $$0P:(DE-He78)b11ccde1801d45d32a6a60f7b396d7dc$$aBandapalli, Obul Reddy$$b23
000177491 7001_ $$aKavi Kishor, Polavarapu Bilhan$$b24
000177491 7001_ $$aSuravajhala, Prashanth$$b25
000177491 773__ $$0PERI:(DE-600)2606827-8$$a10.3389/fimmu.2021.724914$$gVol. 12, p. 724914$$p724914$$tFrontiers in immunology$$v12$$x1664-3224$$y2021
000177491 909CO $$ooai:inrepo02.dkfz.de:177491$$pVDB
000177491 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)b11ccde1801d45d32a6a60f7b396d7dc$$aDeutsches Krebsforschungszentrum$$b23$$kDKFZ
000177491 9131_ $$0G:(DE-HGF)POF4-312$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunktionelle und strukturelle Genomforschung$$x0
000177491 9141_ $$y2021
000177491 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bFRONT IMMUNOL : 2019$$d2021-01-29
000177491 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-01-29
000177491 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-01-29
000177491 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2021-01-29
000177491 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-01-29
000177491 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-01-29
000177491 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2021-01-29
000177491 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2021-01-29
000177491 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-01-29
000177491 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-29
000177491 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-29
000177491 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-01-29
000177491 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bFRONT IMMUNOL : 2019$$d2021-01-29
000177491 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2021-01-29
000177491 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2021-01-29
000177491 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x0
000177491 980__ $$ajournal
000177491 980__ $$aVDB
000177491 980__ $$aI:(DE-He78)B062-20160331
000177491 980__ $$aUNRESTRICTED